Community Research and Development Information Service - CORDIS

Development and Evaluation of Nanomedicines for Cancer Treatment through Immunomodulation: Targeting Tumor-Associated Macrophages

From 2015-05-20 to 2017-05-19, ongoing project

Project details

Total cost:

EUR 168 277,20

EU contribution:

EUR 168 277,20

Coordinated in:

Italy

Call for proposal:

H2020-MSCA-IF-2014See other projects for this call

Funding scheme:

MSCA-IF-EF-ST - Standard EF

Objective

Coordinator

HUMANITAS MIRASOLE SPA
Italy

EU contribution: EUR 168 277,20


Via Manzoni, 56
20089 ROZZANO-MILAN
Italy
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
Record Number: 196682 / Last updated on: 2016-05-13